Charu Chaudhry has extensive experience in biochemical, biophysical, and mechanistic studies across various therapeutic areas. With a background in chemistry and molecular biophysics, Charu has held key research positions at Johnson & Johnson and Bristol-Myers Squibb. Charu's expertise includes assay development, high throughput screening, hit assessment, lead optimization, and small molecule structure-based drug discovery. Additionally, Charu has conducted structural, biophysical, and biochemical studies related to neurophysiology and biophysics during research fellowships at the National Institutes of Health and Rockefeller University.
September, 2021 - present
March, 2020